COVID – 19 Vaccination | Update – Day 400

ad
Measles Rubella vaccination 2nd phase campaign rolled out
Vaccination

India’s COVID-19 vaccination coverage has crossed 175.33 Crore (1,75,33,01,956today. More than 27 lakh (27,47,926Vaccine Doses have been administered till 7 pm today. More than 1.89 Crore (1,89,07,829) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10400623
2nd Dose 9951894
Precaution Dose 4043680
FLWs 1st Dose 18407812
2nd Dose 17415259
Precaution Dose 5866885
Age Group 15-18 years 1st Dose 53600900
2nd Dose 21474441
Age Group 18-44 years 1st Dose 550259080
2nd Dose 435379382
Age Group 45-59 years 1st Dose 202023623
2nd Dose 178246787
Over 60 years 1st Dose 126192350
2nd Dose 111041976
Precaution Dose 8997264
Cumulative 1st dose administered 960884388
Cumulative 2nd dose administered 773509739
Precaution Dose 18907829
Total 1753301956

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 19th February, 2022 (400th Day)
HCWs 1st Dose 111
2nd Dose 1968
Precaution Dose 19821
FLWs 1st Dose 357
2nd Dose 3581
Precaution Dose 82162
Age Group 15-18 years 1st Dose 158927
2nd Dose 757512
Age Group 18-44 years 1st Dose 208134
2nd Dose 1019826
Age Group 45-59 years 1st Dose 33181
2nd Dose 208133
Over 60 years 1st Dose 28017
2nd Dose 126152
Precaution Dose 100044
Cumulative 1st dose administered 428727
Cumulative 2nd dose administered 2117172
Precaution Dose 202027
Total 2747926

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply